Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib + Cyclophosphamide in Platinum-resistant Ovarian Cancer
NCT01238770Phase 2Completed
- Start
- Nov 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC). Started Nov 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01238770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238770.